Ocular Surface Disease

Reviews the latest diagnostic and therapeutic strategies

Covers advanced medical and surgical treatment approaches

Contains a wealth of expert practical knowledge and useful pearls

Reviews the latest diagnostic and therapeutic strategies Covers advanced medical and surgical treatment approaches Contains a wealth of expert practical knowledge and useful pearls

Autorentext
Ali R. Djalilian, MD, is Associate Professor of Ophthalmology and Adjunct Associate Professor of Bio-engineering in the Department of Ophthalmology & Visual Sciences, University of Illinois Eye and Ear Infirmary, University of Illinois at Chicago, USA. Dr. Djalilian is a Diplomate of the American Board of Ophthalmology. He gained his medical degree from the University of Minnesota in 1995 and subsequently undertook an Ophthalmology Residency at the university and Clinical Fellowships in Cornea and Ocular Surface Disorders (Cincinnati Eye Institute, Cincinnati, Ohio) and Ocular Immunology & Uveitis (National Eye Institute, Bethesda, Maryland). Prior to joining the University of Illinois Eye and Ear Infirmary, he completed research training in epithelial cell biology at the National Human Genome Research Institute, NIH (Bethesda, Maryland). Dr. Djalilian has appeared five times in Best Doctors in America and received an American Academy of Ophthalmology Merit Award in 2009. He is a guestreviewer for a number of leading journals and is the author of more than 60 articles in peer-reviewed journals as well as over 20 book chapters.

Inhalt
Medical: New Treatments for Dry Eye Disease.- The Role of in vivo Corneal Imaging in the Diagnosis and Management of OSD.- Current Management of GVHD.- Contact Lenses in the Management of OSD.- Diagnosis and Current Treatment Strategies for Chronic Cicatricial Conjunctivitis. Surgical: The Use of Amniotic Membrane in OSD.- Medical and Surgical Management of Acute SJS.- Limbal Transplantation - Current Surgical Techniques.- Limbal Transplantation - Pre and Post-Operative Strategies to Improve the Outcomes.- Cell Based Therapies for OSD.- Boston Kpro for Severe OSD.